The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-323-4605, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Abbvie Us Llc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 5 commercial cross-references from 4 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-323-4605 |
| Primary Part Number | NDC00074-7068-19 |
| Item Name | Levothyroxine Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Abbvie Us Llc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Active Medicament Medicinal Strength | 0.125 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| SYNTHROID TABLETS | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
| NDC69238-1836-07 | Amneal Pharmaceuticals of New York, Llc (USA) |
| A90E04 | Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa (USA) |
| SYNTHROID | Abbott Laboratories Inc. Div Hospital Products Division (USA) |
| NDC00074-7068-19 PRIMARY | Abbvie Us Llc (USA) |
NSN 6505-01-323-4605 is a Levothyroxine Sodium Tablets, manufactured by Abbvie Us Llc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-323-4605 has 5 cross-referenced part numbers: SYNTHROID TABLETS (Abbott Laboratories Inc. Div Hospital Products Division), NDC69238-1836-07 (Amneal Pharmaceuticals of New York, Llc), A90E04 (Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa), SYNTHROID (Abbott Laboratories Inc. Div Hospital Products Division), NDC00074-7068-19 (Abbvie Us Llc).
There are 12 known substitutes for 6505-01-323-4605: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00074-7068-19: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Primary Container Content Quantity: 1000.000 TABLETS; Active Medicament Medicinal Strength: 0.125 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT. 5 total characteristics are documented in the Federal Logistics Information System.